Floatz logo

Therapeutic Asset Ratings

6,308 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
AUTOLOGOUS RAPAMYCIN-RESISTANT TH1/TC1 CELLS RAPA-201
Skin Squamous Cell Carcinoma
Rapa Therapeutics LLCP1/2CCC (48)
Avapritinib
Acute Myeloid Leukemia With Abnormal Bone Marrow Eosinophils Inv(16)(P13q22) Or T(16;16)(P13;Q22)
The First Affiliated Hospital of Soochow UniversityP1/2CCC (48)
Avapritinib
Acute Myeloid Leukemia With T(8;21)(Q22;Q22) Translocation
The First Affiliated Hospital of Soochow UniversityP1/2CCC (48)
Avelumab
Metastatic Malignant Neoplasm
Aulos Bioscience, Inc.P1/2CCC (48)
Avelumab
Refractory Malignant Neoplasm
M.D. Anderson Cancer CenterP1/2CCC (48)
avm0703
Lymphoid Neoplasm
AVM Biotechnology IncP1/2CCC (48)
AVOTACICLIB
Malignant Pancreatic Neoplasm
BeyondBio Inc.P1/2CCC (48)
Avr-Rd-02
Gaucher Disease
John BernatP1/2CCC (48)
Avzo-021
Breast Cancer
Avenzo Therapeutics, Inc.P1/2CCC (48)
Avzo-023
Breast Cancer
Avenzo Therapeutics, Inc.P1/2CCC (48)
Avzo-1418
Biliary Tract Cancer
Avenzo Therapeutics, Inc.P1/2CCC (48)
Avzo-1418
Lung Cancer
Avenzo Therapeutics, Inc.P1/2CCC (48)
Axitinib
Thyroid Gland Papillary Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP1/2CCC (48)
axp107-11
Amyloidosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sP1/2CCC (48)
Azacitidine
Acute Disease
Molecular Partners AGP1/2CCC (48)
Azacitidine
Chronic Eosinophilic Leukemia
M.D. Anderson Cancer CenterP1/2CCC (48)
Azacitidine
Chronic Neutrophilic Leukemia
M.D. Anderson Cancer CenterP1/2CCC (48)
Azacitidine
Myelodysplastic Syndrome With Ring Sideroblasts
National Cancer Institute (NCI)P1/2CCC (48)
Azacitidine
Myeloproliferative Neoplasm, Unclassifiable
M.D. Anderson Cancer CenterP1/2CCC (48)
Azacitidine
Cellular Phase Chronic Idiopathic Myelofibrosis
M.D. Anderson Cancer CenterP1/2CCC (48)
Azacitidine
Myelodysplastic Syndrome With Single Lineage Dysplasia
National Cancer Institute (NCI)P1/2CCC (48)
AZD2287
Metastatic Prostate Carcinoma
AstraZenecaP1/2CCC (48)
azd3470
Angioimmunoblastic T-Cell Lymphoma
AstraZenecaP1/2CCC (48)
azd3470
Anaplastic Large Cell Lymphoma
AstraZenecaP1/2CCC (48)
azd3470
Peripheral T-Cell Lymphoma, Not Otherwise Specified
AstraZenecaP1/2CCC (48)
Showing 826 to 850 of 6,308 assets
PreviousPage 34 of 253Next